Antimicrobial susceptibility of Shigella sonnei isolates in Japan and molecular analysis of S. sonnei isolates with reduced susceptibility to fluoroquinolones

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 3, 2005, Pages 1203-1205

  Hirose, Kenji ^a   Terajima, Jun ^a   Izumiya, Hidemasa ^a   Tamura, Kazumichi ^a   Arakawa, Eiji ^a   Takai, Nobuko ^a   Watanabe, Haruo ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFOPERAZONE; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; KANAMYCIN; LEVOFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; STREPTOMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; JAPAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SHIGELLA SONNEI;

DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; SHIGELLA SONNEI;

EID: 14744272847     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.3.1203-1205.2005     Document Type: Article

References (13)

1. Aarestrup, F. M., C. Wiuff, K. Molbak, and E. J. Threlfall. 2003. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob. Agents Chemother. 47:827-829. (Letter.)
2. Bhattacharya, S. K., K. Sarkar, B. G. Nair, A. S. Faruque, and D. A. Sack. 2003. Multidrug-resistant Shigella dysenteriae type 1 in south Asia. Lancet Infect. Dis. 3:755.
3. Bopp, C., F. W. Brenner, P. I. Fields, J. G. Wells, and N. A. Strockbine. 2003. Escherichia, Shigella, and Salmonella, p. 654-671. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. ASM Press, Washington, D.C.
4. Chu, Y.-W., E. T. S. Houang, and A. F. B. Cheng. 1998. Novel combination of mutations in the DNA gyrase and topoisomerase IV genes in laboratory-grown fluoroquinolone-resistant Shigella flexneri mutants. Antimicrob. Agents Chemother. 42:3051-3052.
5. Chu, Y.-W., E. T. S. Houang, D. J. Lyon, J. M. Ling, T.-K. Ng, and A. F. Cheng. 1998. Antimicrobial resistance in Shigella flexneri and Shigella sonnei in Hong Kong, 1986 to 1995. Antimicrob. Agents Chemother. 42:440-443.
6. Dagan, D., N. Orr, M. Yavzori, Y. Yuhas, D. Meron, S. Ashkenazi, and D. Cohen. 2002. Retrospective analysis of the first clonal outbreak of nalidixic acid-resistant Shigella sonnei shigellosis in Israel. Eur. J. Clin. Microbiol. Infect. Dis. 21:887-889.
7. Hirose, K., A. Hashimoto, K. Tamura, Y. Kawamura, T. Ezaki, H. Sagara, and H. Watanabe. 2002. DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A. Antimicrob. Agents Chemother. 46:3249-3252.
8. Hirose, K., K. Tamura, H. Sagara, and H. Watanabe. 2001. Antibiotic susceptibilities of Salmonella enterica serovar Typhi and S. enterica serovar Paratyphi A isolated from patients in Japan. Antimicrob. Agents Chemother. 45:955-958.
9. Kotloff, K. L., J. P. Winickoff, B. Ivanoff, J. D. Clemens, D. L. Swerdlow, P. J. Sansonetti, G. K. Adak, and M. M. Levine. 1999. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. W. H. O. 77:651-666.
10. Naheed, A., P. Kalluri, K. A. Talukder, A. S. Faruque, F. Khatun, G. B. Nair, E. D. Mintz, and R. F. Breiman. 2004. Fluoroquinolone-resistant Shigella dysenteriae type 1 in northeastern Bangladesh. Lancet Infect. Dis. 4:607-608.
11. National Committee for Clinical Laboratory Standards. 2000. Method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standards M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
12. National Institute of Infectious Diseases. 2003. Shigellosis, Japan. 2001-2002. Infect. Agents Surveillance Rep. 24:1-2.
13. Threlfall, E. J., J. A. Skinner, and L. R. Ward. 2001. Detection of decreased in vitro susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A. J. Antimicrob. Chemother. 48:740-741.